[The antiarrhythmic action mechanism of verapamil (Isoptin)].
D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004336:Drug Antagonism; D006329:Heart Conduction System / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007275:Injections, Intravenous; D009921:Metaproterenol / Q000494:pharmacology; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
D009921:Metaproterenol; D001285:Atropine; D014700:Verapamil
Ein Beitrag zum antiarrhythmischen Wirkungsmechanismus von Verapamil (Isoptin.